BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
Clinical trial NCT00112775 · UNKNOWN
Trial details
- NCT number
- NCT00112775
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.